BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38559561)

  • 1. Single brain metastases - prognostic factors and impact of residual tumor burden on overall survival.
    Baumgart L; Anetsberger A; Aftahy AK; Wiestler B; Bernhardt D; Combs SE; Meyer HS; Schneider G; Meyer B; Gempt J
    Front Oncol; 2024; 14():1330492. PubMed ID: 38559561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metastases in the elderly - Impact of residual tumor volume on overall survival.
    Baumgart L; Aftahy AK; Anetsberger A; Thunstedt D; Wiestler B; Bernhardt D; Combs SE; Meyer B; Meyer HS; Gempt J
    Front Oncol; 2023; 13():1149628. PubMed ID: 37081991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 4. The Impact of Postoperative Tumor Burden on Patients With Brain Metastases.
    Aftahy AK; Barz M; Lange N; Baumgart L; Thunstedt C; Eller MA; Wiestler B; Bernhardt D; Combs SE; Jost PJ; Delbridge C; Liesche-Starnecker F; Meyer B; Gempt J
    Front Oncol; 2022; 12():869764. PubMed ID: 35600394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases-Retrospective Analysis of 219 Patients.
    Lin J; Kaiser Y; Wiestler B; Bernhardt D; Combs SE; Delbridge C; Meyer B; Gempt J; Aftahy AK
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
    Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
    Sauvageot S; Mollevi C; Thomas QD; Charissoux M; Darlix A; Rigau V; Bauchet L; Quantin X; Pujol JL; Roch B; Boetto J
    J Neurosurg; 2024 Jan; ():1-11. PubMed ID: 38241682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
    Yomo S; Hayashi M
    BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of upfront stereotactic radiosurgery for brain metastases with high cumulative intracranial tumor volume (> 7 ml): analysis of 233 consecutive patients.
    Yomo S; Oda K; Oguchi K
    Acta Neurochir (Wien); 2021 Apr; 163(4):991-1001. PubMed ID: 33398539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
    Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
    Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study.
    Hao Y; Tang T; Ren J; Li G
    Radiol Med; 2023 Oct; 128(10):1271-1283. PubMed ID: 37648956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Debatable Benefit of Gross-Total Resection of Brain Metastases in a Comprehensive Treatment Setting.
    Jünger ST; Pennig L; Schödel P; Goldbrunner R; Friker L; Kocher M; Proescholdt M; Grau S
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801110
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.
    Likhacheva A; Pinnix CC; Parikh NR; Allen PK; McAleer MF; Chiu MS; Sulman EP; Mahajan A; Guha-Thakurta N; Prabhu SS; Cahill DP; Luo D; Shiu AS; Brown PD; Chang EL
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):656-61. PubMed ID: 22898384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factors.
    Hahnemann L; Krämer A; Fink C; Jungk C; Thomas M; Christopoulos P; Lischalk JW; Meis J; Hörner-Rieber J; Eichkorn T; Deng M; Lang K; Paul A; Meixner E; Weykamp F; Debus J; König L
    Clin Transl Radiat Oncol; 2024 May; 46():100782. PubMed ID: 38694237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
    Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
    Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.